Marking and striking a commitment to lower costs and drive through a regulatory regime to that goal and then providing access to disrupt and bypass, I'll say it, Big Pharma to disrupt this multi billion dollar market. 90% of insulins in this country, 90% share on the hands of just three big companies. And they have been gouging you for years and years and years. They're also gouging Americans by five to ten times what our European counterparts are currently paying. (18:03–18:12)
CLAIM
Asserts that three companies control 90% of the insulin market in the U.S.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.